Bernard A. Fischer, Eugen Davids, Markus Gastpar,
Aripiprazol ist ein atypisches Antipsychotikum mit einer etwa 30 %igen intrinsischen dopaminagonistischen Aktivität. Zusätzlich wirkt Aripiprazol als ein 5-HT1A-Agonist und 5-HT2A- ... Psychosen, bei chronischen Schizophrenien sowie bei schizoaffektiven Störungen. Aripiprazol zeigte sich effektiv sowohl in der Behandlung produktiv- ... der Negativsymptomatik. Im Vergleich zu anderen Antipsychotika zeigte Aripiprazol ein günstiges Nebenwirkungsprofil mit geringer Gewichtszunahme, geringer extrapyramidal- ... Die ersten Auswertungen zu Studien zum Einsatz von Aripiprazol bei der bipolaren Manie zeigten eine signifikante Wirksamkeit.
Tópico(s): Electroconvulsive Therapy Studies
2004 - Thieme Medical Publishers (Germany) | Fortschritte der Neurologie · Psychiatrie
Miquel Bernardo, Gisela Mezquida, Paula Ferré, Bibiana Cabrera, M. Torra, Ana Maria Lizana, Merçè Brunet,
... la monitorización de algunos antipsicóticos de uso común (aripiprazol, clozapina y paliperidona) y evaluar su utilidad como ... un episodio y que seguían tratamiento con antipsicóticos: aripiprazol (7 casos), clozapina (17), paliperidona (11). Para la ... con los obtenidos en sangre venosa/plasma. El aripiprazol, la paliperidona y la clozapina mostraron de buenas ... y las del DBS para la paliperidona, el aripiprazol, la clozapina y sus metabolitos fue moderada, lo ... para el DBS. En este estudio, para el aripiprazol, el dehidroaripiprazol, la paliperidona, la clozapina y la ...
Tópico(s): Tryptophan and brain disorders
2022 - Elsevier BV | Revista de Psiquiatría y Salud Mental
Jan Frölich, Martina Starck, Tobias Banaschewski, Gerd Lehmkuhl,
... sollen Hinweise zur Wirksamkeit des partiellen Dopamin-Agonisten, Aripiprazol, geben, welches sich in der Behandlung von Ticstörungen ... werden mussten, wurden mindestens acht Wochen lang mit Aripiprazol behandelt. Vor und nach der Behandlung beantworteten die ... und Weinerlichkeit auf. Behandlungsabbrüche wurden nicht beobachtet. Schlussfolgerungen: Aripiprazol stellt womöglich eine wirkungsvolle und gut verträgliche, nebenwirkungsarme ...
Tópico(s): Autism Spectrum Disorder Research
2010 - Hogrefe Verlag | Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie

... uma paciente que apresentou gagueira apos introducao do aripiprazol e com boa resposta a introducao da risperidona, ... hemogramas mensais, a medicacao foi suspensa e iniciado aripiprazol 15mg/dia com posterior aumento da dose para ...
Tópico(s): Bipolar Disorder and Treatment
2009 - Associação Brasileira de Psiquiatria | Brazilian Journal of Psychiatry
Zoltán Makkos, Lilla Fejes, Gabriella Inczédy-Farkas, Ákos Kassai-Farkas, Gábor Faludi, Judit Lazáry,
... chance to get olanzapine for acute therapy and aripiprazol for long term therapy was more than two ... OR = 2.66, OR = 3.67, respectively). However, aripiprazol was used for acute therapy with significantly lower ...
Tópico(s): Bipolar Disorder and Treatment
2010 - Elsevier BV | Progress in Neuro-Psychopharmacology and Biological Psychiatry
... Neuroleptika stellt eine Rarität dar. Bei Anwendung von Aripiprazol häufen sich jedoch Mitteilungen, nach denen es zu ...
Tópico(s): Gambling Behavior and Treatments
2019 - Thieme Medical Publishers (Germany) | Psychiatrische Praxis
Ralf Kozian, Gregor Schmid, Sergiu Demian,
... über das Auftreten einer Hypothermie bei Gabe von Aripiprazol bei einem Mann im Alter von 92 Jahren ...
Tópico(s): Diet and metabolism studies
2018 - Thieme Medical Publishers (Germany) | Psychiatrische Praxis
Antoni Benabarre, José Antonio Campos, Felicia Russo, Giancarlo Cerveri, Davide Prestía, Sergio González, Agustín Pérez-Sendino, Luís Gutiérrez-Rojas,
... la evidencia científica sobre el manejo clínico del aripiprazol. Un panel de expertos formado por 7 miembros ... la evidencia clínica de los ensayos clínicos de aripiprazol más relevantes de los últimos 10 años. El aripiprazol por vía oral es eficaz para el tratamiento ... bipolares, y mejora el cumplimiento del tratamiento. El aripiprazol es un fármaco bien tolerado y los efectos ... menos frecuentes que para otros fármacos antipsicóticos. El aripiprazol ha sido bien tolerado cuando se usa en ... consenso del panel de expertos mostraron que el aripiprazol es un tratamiento efectivo y bien tolerado para ...
Tópico(s): Electroconvulsive Therapy Studies
2018 - Elsevier BV | Psiquiatría Biológica
Tezan Bildik, Nazlı Özbaran, Mustafa Küçükköse, Ülkü Akyol Ardıç,
... yaş arasındaki beşi erkek 7 çocuk ve genç aripiprazol ile tedavi edilmiştir. Hastaların tümüne daha önce farklı psikiyatrik ilaçlar ile tedavi uygulanmıştır. Aripiprazol günlük 2.5 ya da 5 mg dozda ... ile 10 mg arasında değişmektedir. Yedi hastanın altısının aripiprazol tedavisinden yararlandığı görülmüştür. Ekstrapiramidal yan etki ya da ajitasyon gözlenmemiştir. Aripiprazol hastalarımızda iyi tolere edilmiştir ve çocuk ve gençlerde ...
Tópico(s): Child and Adolescent Psychosocial and Emotional Development
2010 - Taylor & Francis | Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
Tomás Sánchez-Araña Moreno, José Manuel González Moreno, Teresa Rueda Villar, Sergio Ruiz Doblado,
... psicológicos, sociales y rehabilitadores complementarios. La combinación con aripiprazol, un estabilizador del sistema dopamina-serotonina, podría actuar ... con esta combinación (clozapina 400-600 mg/día + aripiprazol 30 mg/día) y se señala la satisfactoria ...
Tópico(s): Electroconvulsive Therapy Studies
2007 - Elsevier BV | Psiquiatría Biológica
... Antidepressiva (Agomelatin) und atypischen Antipsychotika der neuen Generation (Aripiprazol, Paliperidon).
Tópico(s): Pharmacological Receptor Mechanisms and Effects
2009 - Hogrefe Verlag | Therapeutische Umschau
Brian Ladds, Pierre Thomas, C. Godoy Mejía, David Hauser,
... 15, No. 1Posible síndrome neuroléptico maligno asociado a aripiprazol e imipramina tratado con bromocriptinaMedicina Clínica, Vol. 141, ...
Tópico(s): Schizophrenia research and treatment
2009 - American Psychiatric Association | American Journal of Psychiatry
Antonio L. Aguilar-Shea, Isabel Palomero-Juan, Lucía Sierra Santos, Cristina Gallardo-Mayo,
Tópico(s): Urinary Bladder and Prostate Research
2009 - Elsevier BV | Atención Primaria
... effective, atypical antipsychotics, such as quetiapine, risperidone, and aripiprazol, may be used.
Tópico(s): Neurological Disorders and Treatments
2008 - Wiley | Psychogeriatrics
Yonghua Cui, Yi Zheng, Yang Yunping, Jing Liu, Jun Li,
... revealed no significant impact on cardiac conduction by aripiprazol.In this preliminary open-label trial, aripiprazole showed ...
Tópico(s): Autism Spectrum Disorder Research
2010 - Mary Ann Liebert, Inc. | Journal of Child and Adolescent Psychopharmacology
Tobias Drieling, Nina Biedermann, Leo Schärer, N. Strobl, Jens M. Langosch,
... mit nur geringen Gewichtszunahmen verbunden zu sein. Unter Aripiprazol und Ziprasidon kann mit relativ stabilem Gewicht gerechnet ...
Tópico(s): Diet and metabolism studies
2007 - Thieme Medical Publishers (Germany) | Fortschritte der Neurologie · Psychiatrie
Stefan Löffler, P. Dános, Thomas Schillen, A. Klimke,
... für einige Tage und nachfolgenden Therapieversuch mit Ziprasidon, Aripiprazol oder Clozapin. Diese Atypika weisen im Hinblick auf ...
Tópico(s): Alcoholism and Thiamine Deficiency
2007 - Thieme Medical Publishers (Germany) | Psychiatrische Praxis

Paulo José Ribeiro Teixeira, Fábio Lopes Rocha,
... valpróico. Drogas como o haloperidol, a ziprasidona, o aripiprazol e a lamotrigina não estão associadas a ganho ...
Tópico(s): Schizophrenia research and treatment
2006 - Sociedade de Psiquiatria do Rio Grande do Sul | Revista de Psiquiatria do Rio Grande do Sul
... such as olanzapine, risperidone, quetiapine, amisulpride, ziprasidone or aripiprazol, however, makes it possible to use the positive ...
Tópico(s): Mental Health and Psychiatry
2005 - Thieme Medical Publishers (Germany) | Psychiatrische Praxis

Ana Gabriela Hounie, Alice De Mathis, Aline S. Sampaio, Marcos T. Mercadante,
Tópico(s): Behavioral and Psychological Studies
2004 - Associação Brasileira de Psiquiatria | Brazilian Journal of Psychiatry

Ricardo Alberto Moreno, Doris Hupfeld Moreno, Márcia Britto de Macedo Soares, Roberto Ratzke,
... embora existam estudos sugerindo a eficácia da risperidona, aripiprazol e da clozapina. Resultados preliminares avaliando a eficácia ...
Tópico(s): Pharmacological Effects and Toxicity Studies
2004 - Associação Brasileira de Psiquiatria | Brazilian Journal of Psychiatry
Felix-Martin Werner, Rafael Coveñas,
... antipsychotic drugs, antipsychotic effect, risperidone, olanzapine, clozapine, ziprasidone, aripiprazol, asenapine, questiapine, cariprazine, lurasidone, arrythmia, diabetes mellitus, weight ...
Tópico(s): Mental Health and Psychiatry
2014 - Taylor & Francis | Expert Opinion on Drug Safety
Christian Agudelo, Howard Aizenstein, Jordan F. Karp, Charles F. Reynolds,
... variabilidad de la respuesta terapéutica del tratamiento con aripiprazol (modulador dopaminérgico) y con buprenorfina (modulador opiáceo).La ...
Tópico(s): Advanced Neuroimaging Techniques and Applications
2015 - Laboratoires Servier | Dialogues in Clinical Neuroscience
Blanca Iciar Indave, Silvia Minozzi, P. Pani, Laura Amato,
... antipsychotic drugs studied were risperidone, olanzapine, quetiapine, lamotrigine, aripiprazol, haloperidol and reserpine. Comparing any antipsychotic drugs versus ...
Tópico(s): Treatment of Major Depression
2016 - Elsevier BV | Cochrane library
Martina Pitzer, Guido Engelmann, Thomas Stammschulte,
Extrapyramidal adverse events (EPS) occur less frequently with second-generation antipsychotics (SGAs) than with first-generation antipsychotics (FGAs). Tardive dyskinesia (TD), but not tardive dystonia (TDt), also seems to occur less often in adults. TD was found to occur less frequently in children and adolescents treated with FGAs than in adults. No data are available on TDt, and the data pertaining to SGAs are limited and conflicting. SGAs differ in their profile of adverse events. Aripiprazole is ...
Tópico(s): Botulinum Toxin and Related Neurological Disorders
2016 - Hogrefe Verlag | Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie
S.H. Hamilton, E.T. Edgell, Dennis A. Revicki, Laura A. Genduso, G.D. Tollefson,
... e IMC con el paso de olanzapina a aripiprazol (disminución del peso en kg DM −3.21 [− ...
Tópico(s): Schizophrenia research and treatment
1998 - Elsevier BV | European Neuropsychopharmacology
Ekaterina Stepanova, Susannah Dowling, Molly Phelps, Robert L. Findling,
... particular la irritabilidad y la hiperactividad. Actualmente el aripiprazol y la risperidona están aprobados por la FDA ...
Tópico(s): Child Nutrition and Feeding Issues
2017 - Laboratoires Servier | Dialogues in Clinical Neuroscience
Anna Urban, Wiesław Jerzy Cubała,
... lekami przeciwpsychotycznymi. Wzięto pod uwagę następujące leki: amisulpryd, aripiprazol, klozapinę, kwetiapinę, olanzapinę, risperidon, paliperidon, sertindol, ziprasidon. Przedstawiono ...
Tópico(s): Electroconvulsive Therapy Studies
2017 - Polish Psychiatric Association | Psychiatria Polska
F.J. Navarro‐Triviño, Pilar de Jaime Ruiz, Alejandro Porras‐Segovia, Valeriano Garrido Torres-Puchol,
Acneiform rash is a commonly reported side effect to certain types of medications, including antipsychotic agents. Its clinical presentation consists mainly of papulopustular lesions. Other types of lesions, such as nodular or cystic, can also be observed. Body distribution of the lesions follows a similar pattern to acne vulgaris. Depending on the severity of the case, drug-induced acne may be treated in different ways. In mild cases, the use of topical antibiotics and retinoids in combination ...
Tópico(s): Autoimmune and Inflammatory Disorders
2018 - Wiley | Dermatologic Therapy
Javier Vázquez‐Bourgon, Miguel Ibáñez Alario, Jacqueline Mayoral-van Son, Marcos Gómez‐Revuelta, Rosa Ayesa‐Arriola, M. Juncal Ruíz, Víctor Ortiz‐García de la Foz, Benedicto Crespo‐Facorro,
... abnormalities. This study explores the metabolic effects of aripiprazol, quetiapine and ziprasidone in drug-naïve patients with ...
Tópico(s): Bipolar Disorder and Treatment
2020 - Elsevier BV | European Neuropsychopharmacology